Dr. Benjamin Ungar presented on “Topical roflumilast for treatment of psoriasis: Phase 2b results” in November 2022. Mainstays of psoriasis treatment (topically) such as corticosteroids and vitamin D derivatives are associated with numerous side effects. Roflumilast 0.3% cream presents a safe and effective non-steroidal treatment for chronic plaque psoriasis.
Dr. Benjamin Ungar Topical Roflumilast for the Treatment of Psoriasis [Video]
Categories